Please login to the form below

Not currently logged in
Email:
Password:

ledipasvir/sofosbuvir

This page shows the latest ledipasvir/sofosbuvir news and features for those working in and with pharma, biotech and healthcare.

AbbVie sues NHS England over hep C procurement

AbbVie sues NHS England over hep C procurement

The plan was only made possible by enormous strides in the treatment of HCV and in particular new directly-acting antiviral drugs – pioneered by Gilead Sciences with its Sovaldi (sofosbuvir) and ... treatment – as well as follow-up combinations such

Latest news

More from news
Approximately 1 fully matching, plus 50 partially matching documents found.

Latest Intelligence

  • AbbVie: New firm, new thinking AbbVie: New firm, new thinking

    Gilead Sciences has emerged as the leader in this field with Sovaldi (sofosbuvir) and Harvoni (sofosbuvir/ledipasvir), both of which have already made billions of dollars.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics